Zhu CP - Search Results

1

miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy.

Xu WP, Liu JP, Feng JF, Zhu CP, Yang Y, Zhou WP, Ding J, Huang CK, Cui YL, Ding CH, Zhang X, Lu B, Xie WF. Xu WP, et al. Among authors: zhu cp. Gut. 2020 Jul;69(7):1309-1321. doi: 10.1136/gutjnl-2019-318830. Epub 2019 Nov 14. Gut. 2020. PMID: 31727683

2

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis.

Zhu CP, Shi J, Chen YX, Xie WF, Lin Y. Zhu CP, et al. Radiother Oncol. 2011 May;99(2):108-13. doi: 10.1016/j.radonc.2011.04.001. Epub 2011 May 14. Radiother Oncol. 2011. PMID: 21571383

3

The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo.

Zhu CP, Wang J, Shi B, Hu PF, Ning BF, Zhang Q, Chen F, Chen WS, Zhang X, Xie WF. Zhu CP, et al. Dig Dis Sci. 2015 Jan;60(1):109-17. doi: 10.1007/s10620-014-3290-4. Epub 2014 Aug 17. Dig Dis Sci. 2015. PMID: 25129104

4

FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition.

Wang J, Zhu CP, Hu PF, Qian H, Ning BF, Zhang Q, Chen F, Liu J, Shi B, Zhang X, Xie WF. Wang J, et al. Among authors: zhu cp. Carcinogenesis. 2014 Nov;35(11):2576-83. doi: 10.1093/carcin/bgu180. Epub 2014 Aug 20. Carcinogenesis. 2014. PMID: 25142974

5

Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α.

Zheng BN, Ding CH, Chen SJ, Zhu K, Shao J, Feng J, Xu WP, Cai LY, Zhu CP, Duan W, Ding J, Zhang X, Luo C, Xie WF. Zheng BN, et al. Among authors: zhu cp, zhu k. Theranostics. 2019 Apr 13;9(9):2606-2617. doi: 10.7150/thno.32344. eCollection 2019. Theranostics. 2019. PMID: 31131056 Free PMC article.

6

Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.

Guixé-Muntet S, Zhu CP, Xie WF, Gracia-Sancho J. Guixé-Muntet S, et al. Among authors: zhu cp. Pharmacol Ther. 2020 Nov;215:107626. doi: 10.1016/j.pharmthera.2020.107626. Epub 2020 Jul 11. Pharmacol Ther. 2020. PMID: 32659305 Review.

7

Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell.

Huang R, Deng J, Zhu CP, Liu SQ, Cui YL, Chen F, Zhang X, Tao X, Xie WF. Huang R, et al. Among authors: zhu cp. Biomed Pharmacother. 2023 Apr;160:114396. doi: 10.1016/j.biopha.2023.114396. Epub 2023 Feb 13. Biomed Pharmacother. 2023. PMID: 36791568 Free article.

8

Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.

Liu SQ, Deng X, Zhu CP, Cui YL, Xie WF, Zhang X. Liu SQ, et al. Among authors: zhu cp. J Dig Dis. 2023 Jan;24(1):39-50. doi: 10.1111/1751-2980.13161. Epub 2023 Mar 26. J Dig Dis. 2023. PMID: 36967587

9

Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension.

Zhu CP, Liu SQ, Wang KQ, Xiong HL, Aristu-Zabalza P, Boyer-Díaz Z, Feng JF, Song SH, Luo C, Chen WS, Zhang X, Dong WH, Gracia-Sancho J, Xie WF. Zhu CP, et al. Gastroenterology. 2024 Oct;167(5):993-1007. doi: 10.1053/j.gastro.2024.06.007. Epub 2024 Jun 19. Gastroenterology. 2024. PMID: 38906512

10

The α-1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis.

Xiu AY, Ding Q, Zhu CP, Zhang CQ. Xiu AY, et al. Among authors: zhu cp. Adv Biol (Weinh). 2024 Jun;8(6):e2300513. doi: 10.1002/adbi.202300513. Epub 2024 Mar 17. Adv Biol (Weinh). 2024. PMID: 38494421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters